Expand BEAT Menu
BEAT MENU

BEAT Stock Summary and Trading Ideas (Heartbeam | NASDAQ:BEAT)

Heartbeam (BEAT) Frequently Asked Questions

What does Heartbeam do?

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

What symbol and exchange does Heartbeam stock trade?

Heartbeam trades on the NASDAQ stock market under the symbol BEAT.

What is Heartbeam stock price doing today?

As of April 18, 2024, BEAT stock price declined to $2.09 with 41,555 million shares trading.

What is Heartbeam's Beta?

BEAT has a beta of 1.29, meaning it tends to be more sensitive to market movements. BEAT has a correlation of 0.03 to the broad based SPY ETF.

How much is Heartbeam worth?

BEAT has a market cap of $54.99 million. This is considered a Micro Cap stock.

How much money does Heartbeam make?

Last quarter Heartbeam reported $0 in Revenue and -$.13 earnings per share. This fell short of revenue expectation by $-40,000 and met earnings estimates .

What are the top ETFs holding Heartbeam?

The top ETF exchange traded funds that BEAT belongs to (by Net Assets): VTI, VXF.

Is Heartbeam (BEAT) a good investment?

BEAT stock has underperformed the market in the last year with a return of -12.9%, while SPY returned +22.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BEAT shares. However, BEAT has outperformed the market in the last 3 month and 2 week periods, returning +34.0% and 0.0%, while SPY returned +6.1% and -3.8%, respectively. This indicates BEAT has been having a stronger performance recently.

What is the support and resistance for Heartbeam (BEAT) stock price?

BEAT support price is $2.03 and resistance is $2.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BEAT stock will trade within this expected range on the day.